Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma (pages 1604–1611)Koji Miyahara, Kazuhiro Nouso, Takeshi Tomoda, Sayo Kobayashi, Hiroaki Hagihara, Kenji Kuwaki, Junichi Toshimori, Hideki Onishi, Fusao Ikeda, Yasuhiro Miyake, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki and Kazuhide Yamamoto
Article first published online: 20 OCT 2011 | DOI: 10.1111/j.1440-1746.2011.06887.x